Cargando…
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
Metabolic associated fatty liver disease (MAFLD) is one of the most common causes of chronic liver disease worldwide. To date, there is no FDA-approved treatment, so there is an urgent need to determine its pathophysiology and underlying molecular mechanisms. Autophagy is a lysosomal degradation pat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456355/ https://www.ncbi.nlm.nih.gov/pubmed/36077452 http://dx.doi.org/10.3390/ijms231710055 |